HTI Data Protection Notice
Hospital Treatment Insights (HTI) is a database in which hospital dispensing data is linked with Hospital Episode Statistics (HES), a NHS database containing details of all admissions, A and E attendances and outpatient appointments at NHS hospitals in England. IQVIA is the data controller of the HTI database.
The data in HTI is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). HES data is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver. The dispensing data is generated within the hospital pharmacy when medicines are issued to patients during inpatient stays or outpatient visits.
This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Since these uses are not to do with direct patient care, they are called 'secondary uses'.
HTI data covers approximately 30% of NHS trusts in England.
Each HTI record contains a range of non-identified information about an individual patient admitted to an NHS hospital, including:
- clinical information about diagnoses and operations
- patient information, such as year of birth, gender and ethnicity
- administrative information, such as dates and methods of admission and discharge
- prescription medicines issued directly from the hospital pharmacy
We apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published HTI data. This suppresses small numbers to protect individuals' privacy and to ensure that patient confidentiality is maintained.
HTI data is collected in accordance with the same applicable data protection law as is applied to HES. See further: https://digital.nhs.uk/about-nhs-digital/our-work/keeping-patient-data-safe/gdpr/gdpr-register/hospital-episode-statistics-gdpr/hospital-episode-statistics-hes-gdpr-information.
What information is included in HTI data?
HTI data provides non-identified details about patients’ clinical events which have taken place in hospital. These include:
- Clinical information: diagnoses, procedures, operations
- Additional key information about the patient: year of birth, gender, ethnicity
- Administrative information: waiting times, dates and methods of admission / discharge
- Maternity information: gestation, method and date of delivery, complications, birth weight, length of stay
- Adult Critical Care: high dependency and intensive care dates
- Outpatient attendance: appointment dates, diagnoses, procedures
- Accident and Emergency: attendance dates, diagnoses
- Prescription medicines issued from the pharmacy
- Medical history information.
HTI data does NOT include any direct patient identifiers such as names, addresses, NHS numbers, or full dates of birth.
The purpose for which HTI data is processed
This data may be processed and used for the purpose of medical research strictly to perform protocol driven studies within:
Advanced statistical analysis
- natural history of disease
- health economics and outcomes research
- drug exposures
Drug safety monitoring
- monitoring of adverse events for newly licenced drugs prescribed in secondary care
IQVIA processes the HTI data on the basis of legitimate interests in supporting medical research and because it is necessary for the above scientific research purposes, subject always to appropriate safeguards. Technical and organisation measures are in place to ensure only non-identified data is used.
Who is the data made available to?
IQVIA carries out research on behalf of or makes data available to, the following research groups only:
- Providers of healthcare services including but not limited to:
- Clinical Commissioning Groups
- Commissioning Support Units (CSUs)
- Hospital Trusts
- Private secondary care providers
- Mental Health trusts
- Community Provider Trusts
- NHS England
- Public Health England
- Sustainability and Transformation Partnerships (STPs)
- Health and Wellbeing Boards
- Life science industry
- Pharmaceutical companies
- Medical Device companies
- Industry bodies – limited to the Association of the British Pharmaceutical Industry (ABPI), Ethical Medicines Industry Group (EMIG) and the Proprietary Associated of Great Britain (PAGB)
The HTI database is not used for commercial purposes such as sales targeting or commercial insurance.
HTI Study Protocol Review
For advanced scientific analysis, IQVIA produce bespoke analysis for external organisations on a project by project basis. All requests for bespoke analysis are subject to review by an independent scientific advisory committee (ISEAC) who review the proposed study design. If ISEAC approves the study, it is logged on an access control register and the IQVIA researchers are allowed to access data. The researchers will present the results of their analysis to external organisations in the form of aggregated, small number suppressed tables. These outputs may also take the form of counts, proportions or formulae. HTI data may be accessed by academic researchers for approved protocol research under the same strict conditions applied to IQVIA researchers.
ISEAC is a group of medical and scientific advisors who are independent of IQVIA. For studies based on HTI data the role of this committee is to ensure that any study performed is compliant with the NHS the data sharing agreement and by extension, the Care Act 2014. All ISEAC decisions are binding, and any studies not approved will not be performed unless revised and subsequently approved. ISEAC records of decisions can be made available to NHS Digital under the caveat that they will remain in confidence.
IIQVIA retains data in accordance with UK Medical Research Council (MRC) guidelines which recommend basic research data and related material be retained for a minimum of 10 years after the study has been completed. This is to support good research practice which requires research studies to be reproducible.
IQVIA has implemented an Information Security Management System. IQVIA Solutions UK Ltd and IQVIA Technology Services Ltd are accredited to the ISO 27001 standard.
IQVIA stores the HTI data records on secure servers located in the UK. We have put in place appropriate security measures to prevent unauthorised access to or disclosure of the HTI data. Access to the data is strictly controlled and limited to authorised IQVIA personnel.
Patients have the right to opt out of their data being included in the HTI database via the NHS. Patients also have the right to request the rectification or restriction of processing of their personal data held by the NHS, data, or to object to the processing of such personal data, as well as the right to data portability. Patients would need to contact the NHS to exercise these rights. (https://www.nhs.uk/your-nhs-data-matters/)
Changes to this Notice
We may update this notice from time to time. We encourage you to review this notice periodically to stay informed about how we are using and protecting HTI data. Any changes to this notice take effect immediately after being posted or otherwise provided by us.
Questions and comments regarding this notice should be addressed to Amanda Culley at IQVIA, 210 Pentonville Road, London, N1 9JY or to email@example.com
IQVIA Solutions UK Limited and IQVIA Technology Services Ltd (“IQVIA/we/our”) are part of the IQVIA Inc. group of companies serving the combined industries of health information technologies and clinical research worldwide. We specialise in the provision of products and services including medical research and analytical solutions to healthcare and life sciences organisations. In the UK, IQVIA has collected and supported the research use of non-identified patient data for over 20 years.
We are registered in England and Wales as: IQVIA Technology Services Ltd, registration number: 03566800 and IQVIA Solutions UK Limited, registration number: 00634325 and our registered office is 210 Pentonville Road, London, N1 9JY.